Scott B. Ullem, CVP, Chief Financial Officer at Edwards Lifesciences Corp (EW), sold 26,000 shares at $83.30 ($2.2M) on 2025-11-10, disclosed to the SEC on 2025-11-10.
Scheduled sale ($2.2M) by CVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.02 | 10,026 | $832K | 38.5% |
| 2 | $83.02 | 10,026 | $832K | 38.5% |
| 3 | $83.30 | 2,974 | $248K | 11.5% |
| 4 | $83.30 | 2,974 | $248K | 11.5% |
| Total | $83.08 avg | 26,000 | $2.2M | 100% |
| Filing → |
| EW | SELL | 2025-12-09 | $650K | — | Filing → |
| EW | SELL | 2025-05-09 | $1.7M | — | Filing → |
| EW | SELL | 2025-03-26 | $1.6M | — | Filing → |